The 3 Hopper comps IMU, RAD an CHM went down due to market sentiment and the chair's CR strategies.
But despite that, they are cashed up and progressed significantly and hold top positions among their peers. CHM is most likely the one with the biggest upside. Any reasonable deal would see all 3 shooting up as the market would turn from "Doubting" to "Convinced".
CHM's GBM 1101 and IMU's Azer-Cel are at the same stage, getting ready for a rego-trial. Plus, IMU's HER-Vaxx, ready to be partnered or sold.
That's, according to JC, the stage where M&A becomes serious. The read outs of the above mentioned 3 assets are exceeding the market leaders' data - just a matter of time for the stocks really to rise. It just needs the initial spark, most likely when a bigger player enters the stage.
GLTA
CHM Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)